☰

Edson X. Albuquerque

Affiliations: 
University of Maryland School of Medicine, Baltimore, MD, United States 
Google:
"Edson Albuquerque"
Mean distance: 14.08 (cluster 6)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Ebba Cedergren-Andersson post-doc Umeå University
David Ottoson post-doc Karolinska
Stephen Thesleff post-doc Univ. Lund
Klaus R. Unna post-doc University of Illinois, Chicago

Children

Sign in to add trainee
John M. Sarvey grad student SUNY Buffalo
Murilo Marchioro grad student 1991-1996 Universidade Federal do Rio de Janeiro
Edna F. R. Pereira grad student 1993-1996 University of Maryland Medical School
Luis E. Almeida grad student 2004 University of Maryland Medical School
Girish S. Kulkarni grad student 2012 University of Maryland Medical School
Maria F. Braga post-doc University of Maryland Medical School
Antônio José Lapa post-doc University of Maryland Medical School
Charles Kenneth Meshul post-doc University of Maryland Medical School
Edna F. R. Pereira post-doc 1996-2001 University of Maryland Medical School
Akinori Akaike research scientist University of Maryland Medical School

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Aracava Y, Albuquerque EX, Pereira EFR. (2023) (R,S)-trihexyphenidyl, acting via a muscarinic receptor-independent mechanism, inhibits hippocampal glutamatergic and GABAergic synaptic transmissions: Potential relevance for treatment of organophosphorus intoxication. Neuropharmacology. 109684
Hahn B, Shrieves ME, Olmstead CK, et al. (2019) Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects. Psychopharmacology
Lumsden EW, Troppoli TA, Myers SJ, et al. (2019) Antidepressant-relevant concentrations of the ketamine metabolite (2,6)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America
Zanos P, Moaddel R, Morris PJ, et al. (2018) Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews. 70: 621-660
Zanos P, Moaddel R, Morris P, et al. (2017) 790. Ketamine Exerts NMDAR Inhibition-Independent Antidepressant Actions via Its Hydroxynorketamine Metabolites Biological Psychiatry. 81: S321
Alkondon M, Pereira EF, Todd SW, et al. (2015) Functional G-protein-coupled receptor 35 is expressed by neurons in the CA1 field of the hippocampus. Biochemical Pharmacology. 93: 506-18
Alexandrova EA, Alkondon M, Aracava Y, et al. (2014) Galantamine prevents long-lasting suppression of excitatory synaptic transmission in CA1 pyramidal neurons of soman-challenged guinea pigs. Neurotoxicology. 44: 270-8
Banerjee J, Alkondon M, Albuquerque EX, et al. (2013) Contribution of CA3 and CA1 pyramidal neurons to the tonic α7 nAChR-dependent glutamatergic input to CA1 pyramidal neurons. Neuroscience Letters. 554: 167-71
Alkondon M, Albuquerque EX, Pereira EF. (2013) Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices. Neurotoxicology. 36: 72-81
Albuquerque EX, Schwarcz R. (2013) Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges. Biochemical Pharmacology. 85: 1027-32
See more...